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tensive (HTN) patients. Methods: The study included adults (18 yrs. or older) 
HTN patients covered by commercial and Medicare Supplemental insurance in the 
Truven MarketScan database with an HTN diagnosis between October 2009 and 
December 2011. At least two filled prescriptions for Exforge HCT or two periods 
of minimum 15 days of concurrent use of amlodipine, valsartan and hydrochlo-
rothiazide (FC cohort) were required. Patients were continuously enrolled at least 
12 months before and 12 month after the index prescription and had valsartan 
initial dose of 160 or 320 mg/day. Adherence was measured with proportion of days 
covered (PDC) and medication possession ratio (MPR). Persistence was defined as 
no treatment gap greater than 30 days. Chi-Square tests and independent sample 
t-tests were used after adequate propensity score matching (PSM) (absolute stand-
ardized differences < 0.1) using demographics, comorbidities, pre-index health 
care utilization , pre-index costs and valsartan initial dose. Results: Exforge 
HCT patients (N= 9,221) had better unadjusted outcomes compared to FC patients 
(N= 1,884): higher MPR (81.6% vs 77.0%), PDC (70.0% vs 60.6%) and persistence 
(42.7% vs 23.6%) (all p< 0.0001). After risk-adjustment with PSM, Exforge HCT 
patients also exhibited better outcomes compared to FC patients: higher adher-
ence (85.7% vs 77.0%), higher PDC (73.8% vs 60.6%) and persistence (46.8% vs 23.6%) 
(all p< 0.0001). More patients had MPR> 80% in the Exforge HCT cohort (72.9% vs 
57.5%, p< 0.0001). ConClusions: Real-world data indicate that Exforge HCT is 
associated with improved adherence and persistence compared to amlodipine/
valsartan/hydrochlorothiazide FC. These data should be considered by stakehold-
ers engaged with optimizing outcomes of HTN patients.
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objeCtives: Diet and exercise along with the pharmacological treatment are 
required for an adequate control of blood pressure among hypertensive patients. 
The aim of this study is to identify the drug treatments prescribed and attitudes 
and factors associated with the adherence to these indications. Methods: Socio-
demographic and drug treatment information of hypertensive patients aged 20 years 
and older was obtained from an institutional health survey, Encoprevenimss 2010. 
Statistical relationships between socio-demographic variables and adherence to diet 
and exercise were tested. Two binary logistic regression models were constructed to 
measure the impact of personal attitudes and social and demographic variables on 
the decision of the patient whether to follow these recommendations. Results: 
Captopril was the leading prescribed drug (31.63%), followed by enalapril (22.45%) 
and metopropol (13.58%). The main combination of drugs recommended was cap-
topril with metopropol. Additionally to the pharmacological treatment, 32.47% and 
23.59% of the patients reported full adherence to the diet and exercise indications 
respectively, 24.04% and 15.78% partially complied and 11.03% and 16.63% did not 
comply. At 5% level of significance, statistically significant relationships were found 
between diet and exercise with gender (p-vale= 0.007, p-value= 0.000), as well as 
with age groups (p-value= 0.000). The results from the logistic regressions show 
that patients with lack of interest about the importance of diet and exercise in 
their treatment are less likely to adhere to these recommendations. Furthermore 
individuals that have their blood pressure monthly monitored compared with those 
who make it annually, are two times more likely to comply with diet and 1.25 times 
with exercise. Patients at a higher level of education and at older ages have a greater 
probability to follow these indications. ConClusions: Health campaigns and pro-
grams to encourage patients to monitor frequently their blood pressure are desirable 
in order to improve compliance to non-pharmacological suggestions.
PCV104
the AssoCiAtion of ADherenCe AnD heAlth BehAViors With heAlth 
stAtus Among PAtients With hyPertension in JAPAn
DiBonaventura M.1, Kumar M.2
1Kantar Health, New York, NY, USA, 2Kantar Health, New York, NY
objeCtives: Patients with hypertension in Japan report poor health outcomes, 
particularly quality of life. Although quality of life can be improved with advances 
in treatment, there are other modifiable factors which could also be examined 
as potential targets for intervention. This study investigated the association of 
medication adherence and health behaviors with health status. Methods: Data 
from the Japan 2012 National Health and Wellness Survey (NHWS) were used 
(N= 30,000). Only respondents taking a medication for their hypertension were 
included (n= 3,611). Smoking status, exercise behavior, obesity (measured using 
body mass index), alcohol use, and medication adherence (measured using the 
Morisky Medication Adherence Scale [MMAS-8]) were used as predictors of health 
status (measured using the Short Form-36v2) controlling for demographics and 
comorbidities. Results: A total of 67.2% respondents were male; the mean age 
was 63.11 years. Most patients had a history of smoking (19.6% were current smok-
ers and 36.7% were former smokers) and nearly 30% consumed alcohol daily. On 
average, patients exercised less than 7 days per month and a third of patients were 
either overweight (27.6%) or obese (5.8%). When examining items of the MMAS-8, 
forgetfulness was the most common reason for non-adherence (forgetting, 47.8%; 
difficulty remembering, 28.9%; forgetting when traveling/leaving home, 20.7%). 
Controlling for demographics and comorbidities, the strongest predictors of health 
status were with obesity (b = -2.68 for PCS), exercise (b = 0.14 for PCS), and forget-
ting medications (-1.08 for PCS) (all p< .05). ConClusions: Significant associations 
between adherence and health behaviors and health status were observed. Although 
cross-sectional associations may not translate to causal relationships, these results 
suggest that improved exercise and weight reduction may result in notable health 
status improvements, aside from their well-known clinical benefits. Interventions 
which make it easier for patients to remember their medications could also have 
health status benefits.
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objeCtives: Dyslipidemia has been associated with decrements in health sta-
tus among patients in Japan. Aside from improved treatment regimens, health 
behavior and adherence interventions may also help to improve patient outcomes. 
This study investigated the association of adherence and health behaviors with 
health status among patients with dyslipidemia in Japan. Methods: Data from 
the Japan 2012 National Health and Wellness Survey (NHWS) were used (N= 30,000). 
Only respondents who were using a prescription medication for dyslipidemia 
were included (n= 1,510). Smoking, exercise behavior, obesity (measured using 
body mass index), alcohol use, and medication adherence (measured using the 
Morisky Medication Adherence Scale-8) were self-reported by the patient and used 
as predictors of health status (measured using the physical component summary 
[PCS] and mental component summary of the Short Form-36v2) controlling for 
demographics and comorbidities. Results: The respondents had a mean age of 
61.4 years; slightly more than half (53.2%) were male. Most patients had a his-
tory of smoking (18.6% were current smokers and 33.9% were former smokers) 
and patients exercised a mean of 7.1 days per month. Nearly 30% of patients 
were either overweight (23.9%) or obese (5.0%). Intentional non-adherence was 
high with 52.50% of patients cutting back or stopping their medication on their 
own. Forgetfulness was also common (forgetting, 35.7%; not taking medication in 
the past two weeks, 25.9%; difficulty remembering, 18.3%). Controlling for demo-
graphics and comorbidities, the strongest predictors of health status were with 
smoking (b = -1.04 for PCS), obesity (b = -3.51 for PCS), exercise (b = 0.14 for PCS), 
and forgetting medications (b = -0.75 for PCS) (p< .05). ConClusions: Smoking 
cessation, improved exercise, and weight reduction may all result in significant 
health status improvements among patients with dyslipidemia. Interventions 
which make it easier for patients to remember their medications could have health 
status benefits in this population.
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objeCtives: The prevalence of the clustering of cardiometabolic risk factors 
(CMSRFs) namely hypertension, obesity, hyperlipidemia and diabetes is increasing. 
But there is limited recent information on prevalence, demographic characteris-
tics, quality of life and health care expenditures. Methods: Full year consoli-
dated data of the nationally representative Medical Expenditure Panel Survey 
was used (2009-2010). Many similar clinical conditions coded by the International 
Classification of Diseases (ICD-9-CM) diagnostic code are assimilated together to 
form Clinical Classification Categories (CCC). CCCs were used to identify patients 
with hyperlipidemia and hypertension whereas the interview component was 
used to identify patients with obesity and diabetes. CMS patients were defined 
as patients diagnosed with obesity and any two conditions among hypertension, 
hyperlipidemia and obesity. Prevalence of CMS, quality of life, workdays missed 
and total health care expenditures were determined among patients. Results: 
The prevalence of CMS was found to be 0.92% with the weighted frequency of 
CMS resulting to 2,848,683. Among the quality of life variables, most CMS patients 
reported having little interest in things ‘all the time’ (61.6%). They felt calm (47.1%), 
faced difficulty climbing stairs (35.6%) and walking steps (30%) and experienced 
pain (30%) ‘most of the times’. They ‘sometimes’ faced health limitations (40%), 
had lot of energy (33.7%) and accomplished less due to physical problems (25.5%). 
Most accomplished less (41%), had work limitations ‘none of the time’ (30.3%) 
and faced difficulty standing ‘little of the times’ (33.7%). 37.8% rated their SF-12 
evaluated general health as fair. The total number of workdays missed reported 
by CMS patients were ~3.5 times as compared to patients without CMS (5.12 vs 
1.42). The weighted mean total health care expenditures for CMS patients was 
$5128 vs $492 for those without CMS. ConClusions: The prevalence of CMSRFs 
is increasing alarmingly. They have a detrimental effect on quality of life, work 
productivity and health care expenditures.
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objeCtives: The aims of this study were to compare patient outcomes associ-
ated with TSOAC and warfarin in terms of quality of life (QoL). Methods: We 
conducted a prospective, cross-sectional cohort study in an inner-city population 
treated with warfarin or a TSOAC for more than 3 months. The Duke Anticoagulation 
and Satisfaction Scale (DASS) was used to assess the anticoagulation-related QoL. 
Multivariate linear regression analysis was conducted to evaluate the association 
between TSOAC and QoL, adjusted for potential confounders. Results: A total 
of 138 consecutive patients were enrolled in the study, 73 in the warfarin group 
and 65 in the TSOAC group. Patients treated with a TSOAC were older (63.2±16.1 
vs. 54.9±16, p= 0.002), more likely to be white (33.9% vs.6.9%, p< 0.001), had higher 
education level (4 year college degree or higher, 34.4% vs. 9.6%, p= 0.004), and higher 
annual income (> $30,000, 75.7% vs 35%, p< 0.001), compared with warfarin treated 
patients. Patients treated with TSOAC, reported lower rates of bleeding or throm-
boembolism leading to emergency department visits or hospitalizations during 
the preceding twelve months of therapy, compared with warfarin treated patients 
(13.9% vs. 32.9%, p= 0.01). However, patients on TSOAC reported a higher rate of side 
